Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This clinical research study is being done because there is no effective treatment for
advanced androgen-independent prostate cancer. This study will determine if the combination
of medications (Taxotere and Doxil) are effective in this kind of cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville